Literature DB >> 16819459

Sepsis under siege: a new understanding of sepsis might lead to the development of therapies to treat septic shock.

Philip Hunter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16819459      PMCID: PMC1500822          DOI: 10.1038/sj.embor.7400742

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  5 in total

1.  Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation.

Authors:  A Poltorak; P Ricciardi-Castagnoli; S Citterio; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

2.  The etiology of sepsis: turned inside out.

Authors:  Gregory J Brunn; Jeffrey L Platt
Journal:  Trends Mol Med       Date:  2005-11-18       Impact factor: 11.951

3.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

4.  Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region.

Authors:  A Poltorak; I Smirnova; X He; M Y Liu; C Van Huffel; O McNally; D Birdwell; E Alejos; M Silva; X Du; P Thompson; E K Chan; J Ledesma; B Roe; S Clifton; S N Vogel; B Beutler
Journal:  Blood Cells Mol Dis       Date:  1998-09       Impact factor: 3.039

5.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

  5 in total
  3 in total

1.  A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins.

Authors:  Ricardo Núñez Miguel; Joyce Wong; Julian F Westoll; Heather J Brooks; Luke A J O'Neill; Nicholas J Gay; Clare E Bryant; Tom P Monie
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

2.  Procalcitonin and D-dimer for Predicting 28-Day-Mortality Rate and Sepsis Severity based on SOFA Score; A Cross-sectional Study.

Authors:  Zeinab Naderpour; Mehdi Momeni; Elnaz Vahidi; Javad Safavi; Morteza Saeedi
Journal:  Bull Emerg Trauma       Date:  2019-10

Review 3.  Aminosugar-based immunomodulator lipid A: synthetic approaches.

Authors:  Alla Zamyatina
Journal:  Beilstein J Org Chem       Date:  2018-01-04       Impact factor: 2.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.